Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Flaherty, Kevin R, Wells, Athol U, Cottin, Vincent, Devaraj, Anand, Walsh, Simon L.F, Inoue, Yoshikazu, Richeldi, Luca, Kolb, Martin, Tetzlaff, Kay, Stowasser, Susanne, Coeck, Carl, Clerisme-Beaty, Emmanuelle, Rosenstock, Bernd, Quaresma, Manuel, Haeufel, Thomas, Goeldner, Rainer-Georg, Schlenker-Herceg, Rozsa, Brown, Kevin K
Published in The New England journal of medicine (31.10.2019)
Published in The New England journal of medicine (31.10.2019)
Get full text
Journal Article
Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study
Visvanathan, Sudha, Daniluk, Stefan, Ptaszyński, Rafał, Müller-Ladner, Ulf, Ramanujam, Meera, Rosenstock, Bernd, Eleftheraki, Anastasia G, Vinisko, Richard, Petříková, Alena, Kellner, Herbert, Dokoupilova, Eva, Kwiatkowska, Brygida, Alten, Rieke, Schwabe, Christian, Baum, Patrick, Joseph, David, Fine, Jay S, Padula, Steven J, Steffgen, Jürgen
Published in Annals of the rheumatic diseases (01.06.2019)
Published in Annals of the rheumatic diseases (01.06.2019)
Get full text
Journal Article
Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 655064, an Antagonistic Anti‐CD40 Antibody, in Healthy Subjects: A Potential Novel Treatment for Autoimmune Diseases
Schwabe, Christian, Rosenstock, Bernd, Doan, Thi, Hamilton, Paul, Dunbar, P. Rod, Eleftheraki, Anastasia G., Joseph, David, Hilbert, James, Schoelch, Corinna, Padula, Steven J., Steffgen, Jürgen
Published in Journal of clinical pharmacology (01.12.2018)
Published in Journal of clinical pharmacology (01.12.2018)
Get full text
Journal Article